Skip to main content
Clinical Trials/TCTR20200512002
TCTR20200512002Recruiting未知

Effect of Intravenous Acetaminophen on Postoperative Morphine Consumption in Benign Open Abdominal Gynecological Surgeries: A double-blind, randomized, placebo-controlled trial

Faculty of Medicine, Chiang Mai University0 sites100 target enrollmentStarted: May 12, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 65 Years (—)
Sex
Female

Inclusion Criteria

  • 1.Women aged 18-65 years old
  • 2.Patients who undergoing elective benign open abdominal gynecological surgery
  • 3.American Society of Anesthesiologists (ASA) Class I-III

Exclusion Criteria

  • 1.Patients with known allergy to acetaminophen, parecoxib, sulfonamides, aspirin or opioids
  • 2.Patients with either acute or chronic liver disease (defined as abnormal rising AST ALT, hypoalbuminemia, prolonged INR, or evidence from imaging diagnosis)
  • 3.Patients with moderate to severe pain before surgery
  • 4.Third trimester pregnant patients or lactation period
  • 5.Patients receive any additional neuraxial block or peripheral nerve blocks for pain control
  • 6.Patients with history of opioid abuse or chronic opioid use for greater than 3 months
  • 7.Patients with suspected malignant gynecological disease intraoperatively and undergo extended lymph node dissection or complete surgical staging
  • 8.Patients with contraindication to parecoxib (post CABG surgery, established ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease, inflammatory bowel disease, Child-Pugh score ≥ 10, active peptic ulcer/ GI bleeding, known hypersensitivity to sulfonamides)

Investigators

Sponsor
Faculty of Medicine, Chiang Mai University

Similar Trials